Fig. 4From: Early response assessment and prediction of overall survival after peptide receptor radionuclide therapyWaterfall plot of RECIST 1.1 outcome (response, stable disease or progression) and change in SUL-measurements of RECIST 1.1 target lesions for (a) SULmax after 3 months, (b) SULpeak after 3 months, (c) SULmax after 9 months and (d) SULpeak after 9 monthsBack to article page